• Logo
  • SBMUJournals

Association between variants of the autophagy related gene ATG16L1 in inflammatory bowel diseases and clinical statues

Shaghayegh Baradaran Ghavami, Fateme Kabiri, Mahyar Nourian, Hedieh Balaii, Shabnam Shahrokh, Vahid Chaleshi, Ghazal Sherkat, Farzaneh Shalileh, Hamid Asadzadeh Aghdaei
41

Views

PDF

Abstract

Aim: In the present study, two main variants of ATG16L1 gene, rs2241880 T300A and rs2241879 C/T were evaluated in IBD patients and in remission and flare up phase between Iranian population for the first time.

Background: Inflammatory bowel disease (IBD) has increased a global incidence and prevalence in recently years the world and especially in pediatric. ATG16L1 is the major gene that regulates autophagy pathway. Autophagy pathway also effects on dybiosis.

Materials and methods: Genomic DNA was isolated from peripheral blood samples following salting out extraction method. The genotypes of ATG16L1 polymorphisms rs2241880 T300A and rs2241879 C/T were determined using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.

Results: In this case control study, a total of 101 IBD patients (75 ulcerative colitis [UC] and 26 Crohn’s disease [CD]) and 99 healthy controls were evaluated. In the present study, a significant association was found between rs2241879 single nucleotide polymorphism on ATG16L1 gene and increased risk of IBD between Iranian population (P=0.01). There was no statistically significant relationship between rs2241880 and IBD risk (P= 0.42). Also,the effect on these two variants was investigated in relapse and flare up phase and it was not significant, but in CD, rs2241879 and rs2241880 were a trend for a difference in relapse phase.

Conclusion: The results showed that ATG16L1 gene rs2241879 has significant relationship with increased risk of IBD between Iranian population. Individuals with C allele showed a significant relationship with 1.68-fold increased risk of IBD (P=0.01; adjusted OR=1.68; 95% CI=1.13-2.50).

*Corresponding Author: Hamid Asadzadeh Aghdaei, Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Tel: +98-2122432525, Fax: +98-2122432514, E-mail: hamid.assadzadeh@gmail.com

 

 

 

 

 

Abstract

Introduction: Inflammatory bowel disease (IBD) is on the increase in the world and the number of pediatric cases is increasing.  ATG16L1 is the major gene that regulates autophagy pathway. Autophagy pathway also effects on gut microbiota. In the present study, two main variants of ATG16L1 gene, rs2241880 T300A and rs2241879 C/T were evaluated in IBD patients and in remission and flare up phase between Iranian population for the first time.

Materials and methods: Genomic DNA was isolated from peripheral blood samples following salting out extraction method. The genotypes of ATG16L1 polymorphisms rs2241880 T300A and rs2241879 C/T were determined using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.

Results: In this case control study, a total of 101 IBD (75 ulcerative colitis [UC] and 26 Crohn’s disease [CD]) and 99 healthy controls were evaluated. In the present study, a significant association was found between rs2241879 single nucleotide polymorphism on ATG16L1 gene and risk of IBD in Iranian population (P=0.01). There was no statistically significant relationship between rs2241880 and IBD risk (P= 0.42). The effect of these two variants was investigated in relapse and flare up phase and it was not significant, but in CD, rs2241879 and rs2241880 were a trend for a difference in relapse phase.

Discussion: The results showed that ATG16L1 gene rs2241879 has significant relationship with increased risk of IBD in Iranian diseases status. Individuals with C allele showed a significant relationship with 1.68-fold increased risk of IBD (P=0.01; adjusted OR=1.68; 95% CI=1.13-2.50).

 

Key words: Autophagy, ATG16L1, inflammatory bowel disease (IBD), diseases status.


Keywords

Autophagy, ATG16L1, inflammatory bowel disease (IBD), diseases status.

References

Danese, S., et al., Inflammation and coagulation in inflammatory bowel disease: the clot thickens. The American journal of gastroenterology, 2007. 102(1): p. 174.

Basso, P., et al., Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease. Brazilian Journal of Medical and Biological Research, 2014. 47(9): p. 727-737.

Frolkis, A., et al., Environment and the inflammatory bowel diseases. Canadian Journal of Gastroenterology and Hepatology, 2013. 27(3): p. e18-e24.

Karimkhani, S., et al., Lack of Association between Interleukin 23R (IL-23R) rs10889677 Polymorphism and Inflammatory Bowel Disease Susceptibility In an Iranian Population. Reports of Biochemistry and Molecular Biology, 2018. 7(1): p. 16-22.

Bernstein, C.N., et al., World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflammatory bowel diseases, 2010. 16(1): p. 112-124.

Johansson, M.E., et al., Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut, 2013: p. gutjnl-2012-303207.

Nourian, M., et al., Evaluation of tumor necrosis factor (TNF)-α mRNA expression level and the rs1799964 polymorphism of the TNF-α gene in peripheral mononuclear cells of patients with inflammatory bowel diseases. Biomedical reports, 2017. 6(6): p. 698-702.

Lauriola, M., et al., IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes. International journal of molecular medicine, 2011. 27(3): p. 469-477.

Rivas, M.A., et al., Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nature genetics, 2011. 43(11): p. 1066-1073.

Rioux, J.D., et al., Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nature genetics, 2007. 39(5): p. 596-604.

Randall-Demllo, S., M. Chieppa, and R.D. ERI, Intestinal epithelium and autophagy: partners in gut homeostasis. Frontiers in immunology, 2013. 4: p. 301.

Tamboli, C., et al., Dysbiosis in inflammatory bowel disease. Gut, 2004. 53(1): p. 1-4.

Wolfkamp, S.C., et al., ATG16L1 and NOD2 polymorphisms enhance phagocytosis in monocytes of Crohn’s disease patients. World Journal of Gastroenterology: WJG, 2014. 20(10): p. 2664.

Rubinsztein, D.C., P. Codogno, and B. Levine, Autophagy modulation as a potential therapeutic target for diverse diseases. Nature reviews Drug discovery, 2012. 11(9): p. 709-730.

Salem, M., et al., ATG16L1: a multifunctional susceptibility factor in Crohn disease. Autophagy, 2015. 11(4): p. 585-594.

Saitoh, T., et al., Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production. Nature, 2008. 456(7219): p. 264-268.

Cuervo, A.M., The plasma membrane brings autophagosomes to life. Nature cell biology, 2010. 12(8): p. 735-737.

Henderson, P. and C. Stevens, The role of autophagy in Crohn’s disease. Cells, 2012. 1(3): p. 492-519.

Hampe, J., et al., A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nature genetics, 2007. 39(2): p. 207.

Lakatos, P.L., et al., ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients. Digestive and liver disease, 2008. 40(11): p. 867-873.

Serbati, N., et al., IL23R and ATG16L1 variants in Moroccan patients with inflammatory bowel disease. BMC research notes, 2014. 7(1): p. 570.

Glas, J., et al., The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population. The American journal of gastroenterology, 2008. 103(3): p. 682.

Sartor, R.B. and M. Muehlbauer, Microbial host interactions in IBD: implications for pathogenesis and therapy. Current gastroenterology reports, 2007. 9(6): p. 497-507.

Strisciuglio, C., et al., T300A variant of autophagy ATG16L1 gene is associated with decreased antigen sampling and processing by dendritic cells in pediatric Crohn's disease. Inflammatory bowel diseases, 2013. 19(11): p. 2339-2348.

Yang, S.K., et al., Contribution of IL23R but not ATG16L1 to Crohn's disease susceptibility in Koreans. Inflammatory bowel diseases, 2009. 15(9): p. 1385-1390.

Zhang, H.-F., et al., ATG16L1 T300A polymorphism and Crohn’s disease susceptibility: evidence from 13,022 cases and 17,532 controls. Human genetics, 2009. 125(5-6): p. 627-631.

Veltkamp, C., et al., Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment. Gut, 2011: p. gut. 2010.217117.

Suguna, S., et al., Genomic DNA isolation from human whole blood samples by non enzymatic salting out method. Int J Pharm Pharm Sci, 2014. 6: p. 198-199.

Abegunde, A.T., et al., Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World J Gastroenterol, 2016. 22(27): p. 6296-317.

Wild, P., et al., Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science, 2011. 333(6039): p. 228-233.

MacMicking, J.D., G.A. Taylor, and J.D. McKinney, Immune control of tuberculosis by IFN-γ-inducible LRG-47. Science, 2003. 302(5645): p. 654-659.

Zhang, Q., et al., DAMPs and autophagy: cellular adaptation to injury and unscheduled cell death. Autophagy, 2013. 9(4): p. 451-458.

Zhou, X.-J. and H. Zhang, Autophagy in immunity: implications in etiology of autoimmune/autoinflammatory diseases. Autophagy, 2012. 8(9): p. 1286-1299.

Castaño‐Rodríguez, N., et al., Autophagy in Helicobacter pylori infection and related gastric cancer. Helicobacter, 2015. 20(5): p. 353-369.

Gutiérrez, A., et al., Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn9s disease. Gut, 2014. 63(2): p. 272-280.

Ventola, C.L., Role of pharmacogenomic biomarkers in predicting and improving drug response: part 1: the clinical significance of pharmacogenetic variants. Pharmacy and Therapeutics, 2013. 38(9): p. 545.

Yamazaki, K., et al., Association analysis of genetic variants in IL23R, ATG16L1 and 5p13. 1 loci with Crohn’s disease in Japanese patients. Journal of human genetics, 2007. 52(7): p. 575-583.

Glas, J., et al., The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population. The American journal of gastroenterology, 2008. 103(3): p. 682-691.

Cummings, J., et al., Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility gene. Inflammatory bowel diseases, 2007. 13(8): p. 941-946.




DOI: https://doi.org/10.22037/ghfbb.v12i0.1838